Solid Biosciences Inc.
SLDB
41 insider filings · Latest: Oct 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Feb 19 2:38 AM | Alexander CumboDirector, President and CEO | Sale | 16,644 | $5.82 | $96.9K | 235,405(D) | View → |
| Feb 18, 2026 | Feb 19 2:35 AM | Brooks Gabriel | Proposed Sale | 5,563 | $5.82 | $32.4K | — | View → |
| Feb 18, 2026 | Feb 19 2:35 AM | Cumbo Alexander | Proposed Sale | 16,644 | $5.82 | $96.9K | — | View → |
| Feb 18, 2026 | Feb 19 2:34 AM | Jessie HanrahanChief Regulatory Officer | Sale | 4,134 | $5.82 | $24.1K | 74,318(D) | View → |
| Feb 18, 2026 | Feb 19 2:33 AM | Hanrahan Jessie | Proposed Sale | 4,134 | $5.82 | $24.1K | — | View → |
| Feb 18, 2026 | Feb 19 2:32 AM | Ilan GanotDirector | Sale | 2,658 | $5.82 | $15.5K | 27,474(I) | View → |
| Feb 18, 2026 | Feb 19 2:32 AM | Herzich Paul | Proposed Sale | 3,616 | $5.82 | $21.1K | — | View → |
| Feb 18, 2026 | Feb 19 2:31 AM | Ganot Ilan | Proposed Sale | 2,658 | $5.92 | $15.7K | — | View → |
| Feb 18, 2026 | Feb 19 2:31 AM | Paul HerzichChief Technology Officer | Sale | 3,616 | $5.82 | $21.1K | 72,638(D) | View → |
| Feb 18, 2026 | Feb 19 2:31 AM | David T HowtonChief Operating Officer | Sale | 7,469 | $5.82 | $43.5K | 105,077(D) | View → |
| Feb 18, 2026 | Feb 19 2:30 AM | Howton David T | Proposed Sale | 7,469 | $5.82 | $43.5K | — | View → |
| Feb 18, 2026 | Feb 19 2:28 AM | Gabriel BrooksChief Medical Officer | Sale | 0 | $5.82 | — | 89,466(D) | View → |
| Feb 18, 2026 | Feb 19 2:28 AM | Tan Kevin | Proposed Sale | 5,404 | $5.82 | $31.5K | — | View → |
| Feb 18, 2026 | Feb 19 2:25 AM | Kevin TanCFO & Treasurer | Sale | 5,404 | $5.82 | $31.5K | 99,422(D) | View → |
| Feb 4, 2026 | Feb 6 11:05 PM | David T HowtonChief Operating Officer | Sale | 18,894 | $6.44 | $121.7K | 97,859(D) | View → |
| Feb 4, 2026 | Feb 6 11:01 PM | Alexander CumboDirector, President and CEO | Sale | 48,913 | $6.44 | $315.1K | 222,018(D) | View → |
| Feb 4, 2026 | Feb 6 11:01 PM | Ilan GanotDirector | Sale | 7,205 | $6.44 | $46.4K | 25,271(I) | View → |
| Feb 4, 2026 | Feb 6 11:00 PM | Kevin TanCFO & Treasurer | Sale | 14,783 | $6.44 | $95.2K | 94,201(D) | View → |
| Feb 4, 2026 | Feb 6 10:59 PM | Gabriel BrooksChief Medical Officer | Sale | 12,616 | $6.44 | $81.3K | 84,092(D) | View → |
| Feb 4, 2026 | Feb 6 10:57 PM | Jessie HanrahanChief Regulatory Officer | Sale | 12,348 | $6.44 | $79.5K | 70,327(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 19 2:34 AM | Jessie HanrahanChief Regulatory Officer | Option Exercise | 8,125 | — | 16,250(D) | View → |
| Feb 13, 2026 | Feb 19 2:32 AM | Ilan GanotDirector | Option Exercise | 4,861 | — | 9,722(I) | View → |
| Feb 13, 2026 | Feb 19 2:31 AM | Paul HerzichChief Technology Officer | Option Exercise | 7,187 | — | 14,376(D) | View → |
| Feb 13, 2026 | Feb 19 2:31 AM | David T HowtonChief Operating Officer | Option Exercise | 14,687 | — | 29,376(D) | View → |
| Feb 13, 2026 | Feb 19 2:28 AM | Gabriel BrooksChief Medical Officer | Option Exercise | 10,937 | — | 21,876(D) | View → |
| Feb 13, 2026 | Feb 19 2:25 AM | Kevin TanCFO & Treasurer | Option Exercise | 10,625 | — | 21,250(D) | View → |
| Jan 31, 2026 | Feb 3 1:18 AM | Kevin TanCFO & Treasurer | Option Exercise | 33,075 | — | 99,225(D) | View → |
| Jan 29, 2026 | Feb 3 1:18 AM | Kevin TanCFO & Treasurer | Option Exercise | 56,646 | — | 0(D) | View → |
| Jan 29, 2026 | Feb 3 1:18 AM | Kevin TanCFO & Treasurer | Grant/Award | 280,500 | $6.60 | 93,500(D) | View → |
| Jan 31, 2026 | Feb 3 1:16 AM | Alexander CumboDirector, President and CEO | Option Exercise | 100,400 | — | 301,200(D) | View → |
| Jan 29, 2026 | Feb 3 1:16 AM | Alexander CumboDirector, President and CEO | Grant/Award | 764,750 | $6.60 | 254,900(D) | View → |
| Jan 29, 2026 | Feb 3 1:16 AM | Alexander CumboDirector, President and CEO | Option Exercise | 169,401 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 1:15 AM | Jessie HanrahanChief Regulatory Officer | Option Exercise | 27,625 | — | 82,875(D) | View → |
| Jan 29, 2026 | Feb 3 1:15 AM | Jessie HanrahanChief Regulatory Officer | Grant/Award | 285,000 | $6.60 | 95,000(D) | View → |
| Jan 29, 2026 | Feb 3 1:15 AM | Jessie HanrahanChief Regulatory Officer | Option Exercise | 54,925 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 1:14 AM | Gabriel BrooksChief Medical Officer | Option Exercise | 28,225 | — | 84,675(D) | View → |
| Jan 29, 2026 | Feb 3 1:14 AM | Gabriel BrooksChief Medical Officer | Grant/Award | 311,200 | $6.60 | 103,750(D) | View → |
| Jan 29, 2026 | Feb 3 1:14 AM | Gabriel BrooksChief Medical Officer | Option Exercise | 58,847 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 1:12 AM | David T HowtonChief Operating Officer | Option Exercise | 42,275 | — | 126,825(D) | View → |
| Jan 29, 2026 | Feb 3 1:12 AM | David T HowtonChief Operating Officer | Grant/Award | 315,300 | $6.60 | 105,100(D) | View → |